S1. Plasma protein binding (PPB) assay for PDE9A inhibitors.
PPB of 3r, 3s, and 28s was assayed with a Single-Use RED Plate (Thermo Scientific) and performed by Medicilon Company, Shanghai, China. The compounds were added into 500 µL blank plasma to make 1 and 5 µM concentrations. The plasma and buffer chambers were added respectively by 300 µL samples and 500 µL dialysis buffer (PBS, containing 100 mM sodium phosphate and 150 mM sodium chloride). The unit were sealed and incubated on an orbital shaker at 37°C for 4 hours. After dialysis, 50 µL sample from the buffer chamber was added by 50 µL plasma, while 50 µL PBS was added to the plasma sample. Then, 3-fold volume of methanol containing internal standard were added to precipitate the plasma protein. After centrifugation, the supernatant was injected to a LC/MS/MS for analysis. The bound percentage was calculated by the ratio of peak area for the buffer chamber over that for the plasma chamber. Each measurement was repeated three times and the results are the mean of triplicate determinations. Propranolol and warfarin were used as the positive controls. 
